Plasmaglob 5gm Injection is proven to be effective in preventing both systemic and local infections in bone marrow transplant patients above the age of 20 particularly within the first 100 days posttransplant It is also indicated for the treatment of primary immunodeficiency conditions where there is a significant impairment of the bodys ability to produce antibodies leading to a higher susceptibility to infections This therapy provides the patient with the necessary antibodies that their body is unable to produce enabling them to effectively fight off infections Plasmaglob 5gm Injection can be administered intravenously and is suitable for both children and adults Your doctor will closely monitor you for a period of time after the administration of Human Normal Immunoglobulin to ensure there are no adverse side effects While Plasmaglob 5gm Injection is generally welltolerated there is a possibility of experiencing certain side effects These may include back pain chills flushing warmth sensation in the face ears neck and trunk dizziness headache nausea decreased blood pressure and muscle pain If you encounter any of these side effects or feel generally unwell it is important to inform your doctor There may be measures that can be taken to prevent or reduce these effects Prior to using Plasmaglob 5gm Injection it is crucial to inform your doctor if you have any issues with blood clotting or if you have recently received or plan to receive a vaccination The safety of this medication during pregnancy or breastfeeding is not yet fully known so it is advisable to seek guidance from your doctor in such cases